Association between Vitamin D Intake and Its Beneficial Effect on Cardiometabolic Disorders in Children and Adolescents with Obesity
Main Article Content
Abstract
Introduction-Purpose: It is a fact that there has been a dramatic increase in the global prevalence of overweight children and adolescents with obesity in the last decade. From the existing literature, it has been shown that it is somehow related to the low serum concentration of 25-hydroxyvitamin D (s25(OH)D). Several studies suggest the consumption of vitamin D supplements in children-adolescent patients with obesity, despite its controversial effectiveness. The aim is to detect a correlation and evaluate the intake of vitamin D supplements and its effectiveness in the treatment of metabolic disorders of overweight and obese children-adolescents.
Material and Method: A review of current literature on vitamin D and cardiometabolic syndrome (MetS) in children and adolescents was carried out, using several databases such as PubMed, Cross Ref, Cochrane Library and Google Scholar.
Results: A combination of available sources shows that insufficient vitamin D levels have the potential to affect various aspects of health, including cardiovascular well-being. In children-adolescents with obesity, there is difficulty in increasing vitamin D levels due to its possible thinning in adipose tissue, either due to limited exposure to sunlight or due to low consumption of foods rich in vitamin D. Recommended doses daily vitamin D consumption is usually >4,000IU. A positive impact has been found with vitamin D restoration therapy on insulin secretion and function, improvement of lipid profile and reduction of body mass index (BMI). However, the effect of vitamin D appears to have limited clinical significance and controversial cardiovascular and metabolic effects.
Conclusions: In conclusion, it has been found that the consumption of vitamin D supplements slightly increases s25(OH)D levels in overweight-obese children-adolescents and that there is a link between its increase and its effects on certain complications that follow the disease. Nevertheless, more extensive research, continued vigilance of relevant bodies and parents and efforts to promote effective interventions to improve the health of parents are recommended. overweight children-adolescents.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Gou, H., Wang, Y., Liu, Y., Peng, C., He, W., & Sun, X. (2023). Efficacy of vitamin D supplementation on child and adolescent overweight/obesity: a systematic review and meta-analysis of randomized controlled trials. European Journal of Pediatrics, 182(1), 255–264. https://doi.org/10.1007/s00431-022-04673-8
II. Weiss R., Bremer AA., Lustig RH. What is metabolic syndrome, and why are children getting it? Ann N Y Acad Sci 2013; 128:1:123-140.
III. Muldowney, S., & Kiely, M. (2011). Vitamin D and cardiometabolic health: a review of the evidence. Nutrition Research Reviews, 24(1), 1–20. https://doi.org/10.1017/S0954422410000259
IV. Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2007). International Diabetes Federation: a consensus on Type 2 diabetes prevention. Diabetic Medicine: A Journal of the British Diabetic Association, 24(5), 451–463.
https://doi.org/10.1111/j.1464-5491.2007.02157.x
V. Investigation of cardiovascular risk parameters in adolescents with metabolic syndrome Ummugulsum Can, Sadinaz Akdu, Zafer Bağcı, Muammer Buyukinan Journal: Cardiology in the Young, First ViewPublished online by. (2023). Sadinaz Akdu, Zafer Bağcı, Muammer Buyukinan Journal: Cardiology in the Young, 1–6.
VI. Abdelkefi, A., Achour, W., Ben Othman, T., Ladeb, S., Torjman, L., Lakhal, A., Ben Hassen, A., Hsairi, M., & Ben Abdeladhim, A. (2007). Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection. The Journal of Supportive Oncology, 5(6), 273–278.
VII. Krajewska, M., Witkowska-Sędek, E., Rumińska, M., Kucharska, A. M., Stelmaszczyk-Emmel, A., Sobol, M., Majcher, A., & Pyrżak, B. (2023). The link between vitamin D, chemerin and metabolic profile in overweight and obese children - preliminary results. Frontiers in Endocrinology, 14, 1143755. https://doi.org/10.3389/fendo.2023.1143755
VIII. Γιαννιός, Χ. (2021). The effect of vitamin D supplementation on cardiometabolic risk factors and mental health symptoms in obese children National Documentation Centre (EKT). DOI: 10.12681/eadd/47715
IX. Marquina, C., Mousa, A., Scragg, R., & de Courten, B. (2019). Vitamin D and cardiometabolic disorders: a review of current evidence, genetic determinants and pathomechanisms. Obesity Reviews: An Official Journal of the International Association for the Study of Obesity, 20(2), 262–277. https://doi.org/10.1111/obr.12793
X. Hauger, H., Laursen, R. P., Ritz, C., Mølgaard, C., Lind, M. V., & Damsgaard, C. T. (2020). Effects of vitamin D supplementation on cardiometabolic outcomes in children and adolescents: a systematic review and meta-analysis of randomized controlled trials. European Journal of Nutrition, 59(3), 873–884. https://doi.org/10.1007/s00394-019-02150-x
XI. Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Research Ed.), n71
XII. Jebeile, H., Kelly, A. S., O’Malley, G., & Baur, L. A. (2022). Obesity in children and adolescents: epidemiology, causes, assessment, and management. The Lancet. Diabetes & Endocrinology, 10(5), 351–365. https://doi.org/10.1016/S2213-8587(22)00047-X
XIII. Moukayed, M., & Grant, W. B. (2019). Linking the metabolic syndrome and obesity with vitamin D status: risks and opportunities for improving cardiometabolic health and well-being. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 12, 1437–1447. https://doi.org/10.2147/DMSO.S176933
XIV. Salekzamani, S., Mehralizadeh, H., Ghezel, A., Salekzamani, Y., Jafarabadi, M. A., Bavil, A. S., & Gargari, B. P. (2016). Effect of high-dose vitamin D supplementation on cardiometabolic risk factors in subjects with metabolic syndrome: a randomized controlled double-blind clinical trial. Journal of Endocrinological Investigation, 39(11), 1303–1313. https://doi.org/10.1007/s40618-016-0507-8